Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients
Authors:
- 4 July 2003
- journal article
- clinical trial
- Published by Springer Nature in Annals of Hematology
- Vol. 82 (10) , 654-659